Burden of Multidrug-Resistant Acinetobacter baumannii Infection in Hospitalized Patients in a Tertiary Care Hospital of Nepal

Figures & data

Table 1 Distribution of MDR Acinetobacter baumannii in Various Clinical Specimens

Specimens	Number	Percentage
Respiratory tract specimens	76	47.2
Pus and swabs	44	27.3
CSF and other body fluids	18	11.1
Urine	11	6.8
Blood	10	6.2
Catheter tips	2	1.2
Total	161	100

Table 2 Distribution of MDR Acinetobacter baumannii by Gender and Age Group of Patients

Age Group	Number (%)		Total Number (%)
	Female	Male
≤15 Years	16 (9.9)	16 (9.9)	32 (19.8)
16–32 Years	18 (11.2)	20 (12.4)	38 (23.6)
33–48 Years	13 (8.1)	17 (10.6)	30 (18.7)
49–64 Years	8 (5.0)	17 (10.5)	25 (15.5)
≥65 Years	12 (7.5)	24 (14.9)	36 (22.4)
Total number (%)	67 (41.7)	94 (58.3)	161 (100)

Table 3 Ward Wise Distribution of MDR Acinetobacter baumannii

Wards	Number of MDR Isolates	Percentage
ICUs	80	49.6
Surgical	32	19.9
Medical	23	14.3
Orthopedics	9	5.6
Pediatrics	6	3.7
Maternity	4	2.5
Ophthalmology	4	2.5
Burn	3	1.9
Total	161	100

Figure 1 Percentage of antimicrobial resistance and sensitivity of MDR A. baumannii (N = 161).

Table 4 β-Lactamases Production Among MDR Acinetobacter baumannii

Types of β-Lactamases	Number	Percentage
ESBL	32	19.9
AmpC	62	38.5
MBL	109	67.7
KPC	15	9.3
Co-Producers
ESBL + AmpC	11	6.8
ESBL + MBL	8	5.0
AmpC + MBL	37	23.0
MBL + KPC	9	5.6